CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
5.47
+0.06 (1.11%)
At close: Feb 19, 2026, 4:00 PM EST
5.52
+0.05 (0.91%)
After-hours: Feb 19, 2026, 7:15 PM EST
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $926.81 million as of February 19, 2026. Its market cap has increased by 1,310.67% in one year.
Market Cap
926.81M
Enterprise Value
788.78M
1-Year Change
1,310.67%
Ranking
Category
Stock Price
$5.47
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $926.81M, an increase of 12,424.48%. That is a compound annual growth rate of 59.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 916.60M | 26.99% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 988.86M |
| Theravance Biopharma | 984.57M |
| GH Research | 980.06M |
| Palvella Therapeutics | 974.50M |
| Aktis Oncology | 966.94M |
| AbCellera Biologics | 963.86M |
| ArriVent BioPharma | 953.19M |
| Valneva SE | 937.97M |